Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders

 
 

Omega Therapeutics, Inc. Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-21Dec-31-20Dec-31-19
Revenues0.10.011.9
            Revenue growth -100.0% 
Cost of goods sold0.00.017.3
Gross profit0.10.0-5.4
            Gross margin100.0% -45.3%
Research and development47.921.1 
General and administrative16.66.24.2
EBIT-66.0-28.6-17.3
            EBIT margin-45855.6% -145.3%
Pre-tax income-68.3-29.40.0
Income taxes0.00.00.0
            Tax rate0.0%0.0% 
Net income-68.3-29.40.0
            Net margin-47416.7% 0.0%
 
Diluted EPS($3.05)($7.54) 
Shares outstanding (diluted)22.43.9 
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy